Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Benzoyl peroxide + clindamycin phosphate 50mg/10mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide + clindamycin phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 300mg/2mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
clindamycine 300 mg/2 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide + clindamycin phosphate 50mg/10mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin 1.2%/tretinoin 0.025% topical gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamylin phosphate 900mg/6ml injection solution 6mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 150mg/mL injection solution 4 mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 150mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clindamycin phosphate 150mg/mL injection solution 6mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely clindamycin (as clindamycin phosphate) 100 milligram/1 each conventional release vaginal pessary (clinical drug) |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 300 milligram/2 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 600 milligram/4 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 150 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin phosphate 20 mg/mL vaginal cream |
Has basis of strength substance (attribute) |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin phosphate 20 mg/mL vaginal cream |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has precise active ingredient |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has basis of strength substance (attribute) |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has basis of strength substance (attribute) |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has precise active ingredient |
False |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous foam (clinical drug) |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous foam (clinical drug) |
Has basis of strength substance (attribute) |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has basis of strength substance (attribute) |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 20 milligram/1 gram conventional release vaginal cream (clinical drug) |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin (as clindamycin phosphate) 10 mg/g and tretinoin 250 microgram/g cutaneous gel |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 12 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 6 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin (as clindamycin phosphate) 150 mg/mL solution for infusion and/or injection |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clindamycin (as clindamycin phosphate) 150 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous emulsion |
Has precise active ingredient |
True |
phosphate de clindamycine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |